Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caribbean Extracts is a vertically integrated biotechnology company based in Jamaica that specializes in the extraction and processing of medical-grade cannabinoids. The company utilizes advanced CO2 and ethanol extraction technologies to produce high-purity THC and CBD oils, distillates, and isolates for pharmaceutical and wellness applications. As a licensed processor under the Jamaican Cannabis Licensing Authority, Caribbean Extracts focuses on standardized production methods to meet international quality requirements. Their business model encompasses both the manufacturing of proprietary therapeutic products and providing contract extraction services to other industry participants. The company plays a significant role in the Caribbean's emerging medical cannabis sector by bridging the gap between agricultural cultivation and clinical-grade pharmaceutical ingredients. Their operations are designed to support the development of novel cannabinoid-based therapies for a variety of medical conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caribbean Extracts.